This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Joensuu, H. Articles by Jalkanen, S. Search for Related Content PubMed PubMed Citation Articles by Joensuu, H. Articles by Jalkanen, S.

American Journal of Pathology, Vol 143, 867-874, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Glycoprotein CD44 expression and its association with survival in breast cancer

H Joensuu, PJ Klemi, S Toikkanen and S Jalkanen
Department of Oncology and Radiotherapy, Turku University Central Hospital, University of Turku, Finland.

To investigate the clinical significance of CD44 expression (lymphocyte- homing receptor) in adenocarcinoma, deparaffinized sections from 198 female breast carcinomas were stained with Hermes-3 MoAb for CD44 glycoprotein. In 16% of the cancers most (> or = 90%) of the cancer cells stained positively for CD44, whereas the rest of the cancers were either heterogenous (46%) or negative (38%) in CD44 staining. Cancers with > 50% CD44 positive cells were more often poorly differentiated (grade 3) than those with < or = 50% positive cells (38 vs. 19%, P = 0.006), they had higher mitotic counts (P = 0.04), and were more often estrogen receptor negative (52 vs. 31%, P = 0.01). Among ductal not otherwise specified cancers and node-positive cancers strong CD44 expression was associated with poor outcome (P = 0.05 and 0.02, respectively). However, CD44 expression was not an independent prognostic factor in these subgroups in a multivariate analysis. Unlike in lymphomas the unfavorable prognosis associated with CD44 expression may not be explained by the greater metastatic potential of CD44- positive cells, because the difference in mortality between the groups appeared to diminish with time, and CD44 positivity was associated with aggressive histological features.

This article has been cited by other articles:

				L. K. Diaz, X. Zhou, E. T. Wright, M. Cristofanilli, T. Smith, Y. Yang, N. Sneige, A. Sahin, and M. Z. Gilcrease CD44 Expression Is Associated with Increased Survival in Node-Negative Invasive Breast Carcinoma Clin. Cancer Res., May 1, 2005; 11(9): 3309 - 3314. [Abstract] [Full Text] [PDF]

				A. Iwase, R. Shen, D. Navarro, and D. M. Nanus Direct Binding of Neutral Endopeptidase 24.11 to Ezrin/Radixin/Moesin (ERM) Proteins Competes with the Interaction of CD44 with ERM Proteins J. Biol. Chem., March 19, 2004; 279(12): 11898 - 11905. [Abstract] [Full Text] [PDF]

				Y. Ohene-Abuakwa and M. Pignatelli Adhesion Molecules as Diagnostic Tools in Tumor Pathology International Journal of Surgical Pathology, July 1, 2000; 8(3): 191 - 200. [Abstract] [PDF]

				P. Auvinen, R. Tammi, J. Parkkinen, M. Tammi, U. Agren, R. Johansson, P. Hirvikoski, M. Eskelinen, and V.-M. Kosma Hyaluronan in Peritumoral Stroma and Malignant Cells Associates with Breast Cancer Spreading and Predicts Survival Am. J. Pathol., February 1, 2000; 156(2): 529 - 536. [Abstract] [Full Text] [PDF]

				X. Roca, J. L. Mate, A. Ariza, A. M. Munoz-Marmol, C. von Uexkull-Guldeband, I. Pellicer, J. J. Navas-Palacios, and M. Isamat CD44 Isoform Expression Follows Two Alternative Splicing Pathways in Breast Tissue Am. J. Pathol., July 1, 1998; 153(1): 183 - 190. [Abstract] [Full Text] [PDF]